Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Sachs Says Buy Royal Mail And Intertek

Fri, 07th Nov 2014 09:42

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
GOLDMAN RAISES BABCOCK INTERNATIONAL PRICE TARGET TO 1438 (1380) PENCE - 'BUY'
----------
GOLDMAN RESUMES ROYAL MAIL WITH 'BUY' - TARGET 575 PENCE
----------
GOLDMAN RAISES INTERTEK TO 'BUY' ('NEUTRAL') - TARGET 3440 (3240) PENCE
----------
GOLDMAN RAISES EXPERIAN TO 'NEUTRAL' ('SELL') - TARGET 1078 (985) PENCE
----------
TRADERS: NOMURA RAISES EXPERIAN PRICE TARGET TO 1,130 (1,100) PENCE - 'BUY'
----------
UBS CUTS COCA-COLA HBC TARGET TO 1,360 (1,450) PENCE - 'NEUTRAL'
----------
Nomura Cuts Coca-Cola HBC Price Target To 1,100p From 1,140p, Maintains Reduce
----------
UBS CUTS RSA INSURANCE PRICE TARGET TO 418 (427) PENCE - 'SELL'
----------
EXANE BNP RAISES RSA INSURANCE PRICE TARGET TO 430 (405) PENCE - 'UNDERPERFORM'
----------
UBS RAISES SCHRODERS PRICE TARGET TO 2,800 (2,400) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS GLAXOSMITHKLINE PRICE TARGET TO 1540 (1575) PENCE - 'HOLD'
----------
CITIGROUP RAISES 3I GROUP PRICE TARGET TO 455 (430) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS MORRISON TO 'SELL' ('HOLD') - TARGET 155 (195) PENCE
----------
LBBW RAISES ASTRAZENECA PRICE TARGET TO 3900 (3600) PENCE - 'SELL'
----------
NUMIS CUTS HSBC PRICE TARGET TO 700 (725) PENCE - 'ADD'
----------
NUMIS CUTS RANDGOLD RESOURCES PRICE TARGET TO 4,900 (5,100) PENCE - 'BUY'
----------
S&P CAPITAL IQ RAISES ASTRAZENECA PRICE TARGET TO 4700 (4500) PENCE - 'HOLD'
----------
FTSE 250
----------
GOLDMAN CUTS HAYS PRICE TARGET TO 153 (185) PENCE - 'BUY'
----------
TRADERS: GOLDMAN REMOVES HAYS FROM 'CONVICTION BUY LIST' - STILL 'BUY'
----------
GOLDMAN RAISES FIRSTGROUP PRICE TARGET TO 165 (160) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BERENDSEN PRICE TARGET TO 1170 (1132) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY') - TARGET 467 (570) PENCE
----------
GOLDMAN CUTS HIKMA PHARMA TO 'NEUTRAL' ('BUY') - TARGET 2120 (2250) PENCE
----------
MORGAN STANLEY RAISES WILLIAM HILL TARGET TO 460 (425) PENCE - 'OVERWEIGHT'
----------
TRADERS: SOCGEN CUTS AVEVA GROUP PRICE TARGET TO 2000 (2250) PENCE - 'BUY'
----------
CHARLES STANLEY RAISES COBHAM TO 'HOLD' ('REDUCE')
----------
BARCLAYS CUTS LONMIN PRICE TARGET TO 190 (205) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS HALFORDS GROUP PRICE TARGET TO 385 (400) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS LANCASHIRE HLDGS PRICE TARGET TO 494 (575) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS INITIATES INFINIS ENERGY WITH 'OVERWEIGHT' - TARGET 275 PENCE
----------
TRADERS: JPMORGAN RAISES CRODA PRICE TARGET TO 2,300 (2,250) PENCE - 'NEUTRAL'
----------
HSBC CUTS JD WETHERSPOON PRICE TARGET TO 820 (850) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS TATE & LYLE PRICE TARGET TO 600 (610) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES BIG YELLOW GROUP PRICE TARGET TO 540 (470) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS UBM PRICE TARGET TO 670 (820) PENCE - 'BUY'
----------
CITIGROUP INITIATES POUNDLAND GROUP WITH 'BUY' - TARGET 350 PENCE
----------
TRADERS: JPMORGAN CUTS PLAYTECH TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 615 (860) PENCE
----------
MAIN MARKET AND AIM
----------
CITIGROUP INITIATES B&M WITH 'BUY' - TARGET 310 PENCE
----------
PANMURE RAISES LOOKERS PRICE TARGET TO 175 (166) PENCE - 'BUY'
----------
PANMURE RAISES FILTRONIC PRICE TARGET TO 23 (20) PENCE - 'HOLD'
----------
TRADERS: JPMORGAN CUTS PROMETHEAN TO 'UNDERWEIGHT' ('NEUTRAL')
----------
TRADERS: JPMORGAN RAISES GEM DIAMONDS TARGET TO 280 (270) P - 'OVERWEIGHT'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.